Avaí Bio, Inc. AVAI
$0.12
$0.0113.93%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.67% | -1.19% | -26.74% | -49.15% | -32.58% |
| Depreciation & Amortization | -59.71% | -65.01% | -66.64% | -50.00% | -29.86% |
| Other Operating Expenses | 100.87% | -- | 93.41% | 307.83% | -150.44% |
| Total Operating Expenses | -5.18% | -3.30% | -25.51% | -46.56% | -33.67% |
| Operating Income | 5.18% | 3.30% | 25.51% | 46.56% | 33.67% |
| Income Before Tax | -65.08% | -53.46% | 45.99% | 62.38% | 51.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -65.08% | -53.46% | 45.99% | 62.38% | 51.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -65.08% | -53.46% | 45.99% | 62.38% | 51.07% |
| EBIT | 5.18% | 3.30% | 25.51% | 46.56% | 33.67% |
| EBITDA | 2.85% | 0.16% | 23.10% | 46.42% | 33.83% |
| EPS Basic | -51.19% | -32.63% | 50.67% | 73.41% | 67.19% |
| Normalized Basic EPS | -5.41% | 2.47% | 29.47% | 60.38% | 54.04% |
| EPS Diluted | -51.19% | -32.63% | 50.67% | 73.41% | 67.19% |
| Normalized Diluted EPS | -5.41% | 2.47% | 29.47% | 60.38% | 54.04% |
| Average Basic Shares Outstanding | 6.21% | 7.48% | 5.53% | 19.60% | 30.57% |
| Average Diluted Shares Outstanding | 6.21% | 7.48% | 5.53% | 19.60% | 30.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |